Comment on revisiting the association between anticholinergic burden and frailty in people with HIV

Key Points

• To comment on the relationship between anticholinergic burden and frailty in individuals with HIV.
• Review of existing literature and data related to anticholinergic burden and frailty in HIV
• Analysis of implications for health outcomes in this population.
• No specific data or results provided; highlights the need for further investigation into the topic.